Elena Gimeno-Santos

Dr. Elena Gimeno-Santos

orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 August 2018 in European Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MRMaria A Ramon
Maria A Ramon
GRGerben Ter Riet
Gerben Ter Riet
ACAnne-Elie Carsin
Anne-Elie Carsin
EGElena Gimeno-Santos
Elena Gimeno-Santos
AAAlvar Agustí
Alvar Agustí
JGJudith Garcia-Aymerich
Judith Garcia-Aymerich
The vicious circle of dyspnoea–inactivity has been proposed, but never validated empirically, to explain the clinical course of chronic obstructive pulmonary disease (COPD). We aimed to develop and validate externally a comprehensive vicious circle model.We utilised two methods. 1) Identification and validation of all published vicious circle models by a systematic literature search and fitting structural equation models to longitudinal data from the Spanish PAC-COPD (Phenotype and Course of COPD) cohort (n=210, mean age 68 years, mean forced expiratory volume in 1 s (FEV1) 54% predicted), testing both the hypothesised relationships between variables in the model (“paths”) and model fit. 2) Development of a new model and external validation using longitudinal data from the Swiss and Dutch ICE COLD ERIC (International Collaborative Effort on Chronic Obstructive Lung Disease: Exacerbation Risk Index Cohorts) cohort (n=226, mean age 66 years, mean FEV157% predicted).We identified nine vicious circle models for which structural equation models confirmed most hypothesised paths but showed inappropriate fit. In the new model, airflow limitation, hyperinflation, dyspnoea, physical activity, exercise capacity and COPD exacerbations remained related to other variables and model fit was appropriate. Fitting it to ICE COLD ERIC, all paths were replicated and model fit was appropriate.Previously published vicious circle models do not fully explain the vicious circle concept. We developed and externally validated a new comprehensive model that gives a more relevant role to exercise capacity and COPD exacerbations.

30 August 2018 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
AAAne Arbillaga-Etxarri
Ane Arbillaga-Etxarri
EGElena Gimeno-Santos
Elena Gimeno-Santos
ABAnael Barberan-Garcia
Anael Barberan-Garcia
EBEva Balcells
Eva Balcells
MBMarta Benet
Marta Benet
JGJudith Garcia-Aymerich
Judith Garcia-Aymerich
There is a need to increase and maintain physical activity in patients with chronic obstructive pulmonary disease (COPD). We assessed 12-month efficacy and effectiveness of the Urban Training intervention on physical activity in COPD patients.This randomised controlled trial (NCT01897298) allocated 407 COPD patients from primary and hospital settings 1:1 to usual care (n=205) or Urban Training (n=202). Urban Training consisted of a baseline motivational interview, advice to walk on urban trails designed for COPD patients in outdoor public spaces and other optional components for feedback, motivation, information and support (pedometer, calendar, physical activity brochure, website, phone text messages, walking groups and a phone number). The primary outcome was 12-month change in steps·day−1 measured by accelerometer.Efficacy analysis (with per-protocol analysis set, n=233 classified as adherent to the assigned intervention) showed adjusted (95% CI) 12-month difference +957 (184–1731) steps·day−1 between Urban Training and usual care. Effectiveness analysis (with intention-to-treat analysis set, n=280 patients completing the study at 12 months including unwilling and self-reported non-adherent patients) showed no differences between groups. Leg muscle pain during walks was more frequently reported in Urban Training than usual care, without differences in any of the other adverse events.Urban Training, combining behavioural strategies with unsupervised outdoor walking, was efficacious in increasing physical activity after 12 months in COPD patients, with few safety concerns. However, it was ineffective in the full population including unwilling and self-reported non-adherent patients.

29 September 2023 in Archivos de Bronconeumología
Verified
Journal Article
Open access
Ana Lista-PazAna Lista-Paz
Ana Lista-Paz
DLDaniel Langer
Daniel Langer
MBMargarita Barral-Fernández
Margarita Barral-Fernández
AQAlejandro Quintela-Del-Río
Alejandro Quintela-Del-Río
EGElena Gimeno-Santos
Elena Gimeno-Santos
LGLuz González-Doniz
Luz González-Doniz
Maximal inspiratory and expiratory pressures (PImax/PEmax) reference equations obtained in healthy people are needed to correctly interpret respiratory muscle strength. Currently, no clear cut-off points defining respiratory muscle weakness are available. We aimed to establish sex-specific reference equations for PImax/PEmax in a large sample of healthy adults and to objectively determine cut-off points for respiratory muscle weakness. A multicentre cross-sectional study was conducted across 14 Spanish centres. Healthy non-smoking volunteers aged 18-80 years stratified by sex and age were recruited. PImax/PEmax were assessed using uniform methodology according to international standards. Multiple linear regressions were used to obtain reference equations. Cut-off points for respiratory muscle weakness were established by using T-scores. The final sample consisted of 610 subjects (314 females; 48 [standard deviation, SD: 17] years). Reference equations for PImax/PEmax included body mass index and a squared term of the age as independent variables for both sexes (p<0.01). Cut-off points for respiratory muscle weakness based on T-scores ≥2.5 SD below the peak mean value achieved at a young age were: 62 and 83cmH2O for PImax and 81 and 109cmH2O for PEmax in females and males, respectively. These reference values, based on the largest dataset collected in a European population to date using uniform methodology, help identify cut-off points for respiratory muscle weakness in females and males. These data will help to better identify the presence of respiratory muscle weakness and to determine indications for interventions to improve respiratory muscle function.

21 December 2018 in JMIR mHealth and uHealth
Verified
Journal Article
Open access
MLMatthias Loeckx
Matthias Loeckx
RRRoberto A Rabinovich
Roberto A Rabinovich
HDHeleen Demeyer
Heleen Demeyer
Zafeiris LouvarisZafeiris Louvaris
Zafeiris Louvaris
RTRebecca Tanner
Rebecca Tanner
TTThierry Troosters
Thierry Troosters
Mobile and tablet apps, ubiquitous and pervasive computing, wearable computing and domotics for health.

23 March 2022 in Cancers
Verified
Journal Article
Open access
PDF file
BDBerta Díaz-Feijoó
Berta Díaz-Feijoó
NANúria Agustí
Núria Agustí
Raquel SebioRaquel Sebio
Raquel Sebio
ALAntonio López-Hernández
Antonio López-Hernández
MSMarina Sisó
Marina Sisó
MAMaria José Arguis
Maria José Arguis
Introduction: Treatment for advanced ovarian cancer (AOC) comprises cytoreductive surgery combined with chemotherapy. Multimodal prehabilitation programmes before surgery have demonstrated efficacy in postoperative outcomes in non-gynaecological surgeries. However, the viability and effects of these programmes on patients with AOC are unknown. We aimed to evaluate the feasibility and postoperative impact of a multimodal prehabilitation programme in AOC patients undergoing surgery. Methods: This single-centre, before-and-after intervention pilot study included 34 patients in two cohorts: the prehabilitation cohort prospectively included 15 patients receiving supervised exercise, nutritional optimisation, and psychological preparation from December 2019 to January 2021; the control cohort included 19 consecutive patients between January 2018 and November 2019. Enhanced Recovery After Surgery guidelines were followed. Results: The overall adherence to the multimodal prehabilitation programme was 80%, with 86.7% adherence to exercise training, 100% adherence to nutritional optimisation, and 80% adherence to psychological preparation. The median hospital stay was shorter in the prehabilitation cohort (5 (IQR, 4–6) vs. 7 days (IQR, 5–9) in the control cohort, p = 0.04). Differences in postoperative complications using the comprehensive complication index (CCI) were not significant (CCI score: 9.3 (SD 12.12) in the prehabilitation cohort vs. 16.61 (SD 16.89) in the control cohort, p = 0.08). The median time to starting chemotherapy was shorter in the prehabilitation cohort (25 (IQR, 23–25) vs. 35 days (IQR, 28–45) in the control cohort, p = 0.03). Conclusions: A multimodal prehabilitation programme before cytoreductive surgery is feasible in AOC patients with no major adverse effects, and results in significantly shorter hospital stays and time to starting chemotherapy.

25 January 2018 in European Respiratory Journal
Verified
Journal Article
Open access
PDF file
HDHeleen Demeyer
Heleen Demeyer
MCMarcos Costilla-Frias
Marcos Costilla-Frias
Zafeiris LouvarisZafeiris Louvaris
Zafeiris Louvaris
EGElena Gimeno-Santos
Elena Gimeno-Santos
MTMaggie Tabberer
Maggie Tabberer
JGJudith Garcia-Aymerich
Judith Garcia-Aymerich
Exacerbations have a negative impact on long-term daily physical activity of COPD patientshttp://ow.ly/olGl30hkdMl